STAA Stock Summary and Trading Ideas (Staar Surgical Company | NASDAQ:STAA)

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

Staar Surgical Company trades on the NASDAQ stock market under the symbol STAA.

As of July 21, 2026, STAA stock price climbed to $24.30 with 1,116,376 million shares trading.

STAA has a beta of 1.49, meaning it tends to be more sensitive to market movements. STAA has a correlation of 0.07 to the broad based SPY ETF.

STAA has a market cap of $1.21 billion. This is considered a Small Cap stock.

Last quarter Staar Surgical Company reported $94 million in Revenue and $.10 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.04.

In the last 3 years, STAA traded as high as $58.35 and as low as $13.50.

The top ETF exchange traded funds that STAA belongs to (by Net Assets): IJR, VTI, IWM, VB, VXF.

STAA has outperformed the market in the last year with a return of +40.0%, while the SPY ETF gained +20.4%. However, in the most recent history, STAA shares have underperformed the stock market with its stock returning -4.8% in the last 3 month period and -11.1% for the last 2 week period, while SPY has returned +5.9% and -0.4%, respectively.

STAA support price is $22.94 and resistance is $25.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STAA shares will trade within this expected range on the day.